However, shares of the U.S. drugmaker fell about 12% in premarket trading after it reported data from its oral weight loss ...

Eli Lilly released the results for experimental weight-loss pill study early Thursday, ahead of its scheduled second-quarter ...

Eli Lilly's pill, orforglipron, is one step closer to becoming the first new, needle-free alternative in the booming market ...

Eli Lilly has hoped its candidate weight loss pill would safeguard its lead in the obesity market, but new results may prove ...